Challenges of using AI-based synthetic data in health economics and outcomes research
- 28 May 2026
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 26 (5) , 567-576
Abstract
1. Data is an important asset to improve healthcare through its utility in clinical studies and public health efforts. There is a need to access vast amounts of high-quality data to gather evidence...Keywords
This publication has 42 references indexed in Scilit:
- Review of generative AI for synthetic data generation: a healthcare perspectiveArtificial Intelligence Review, 2025
- Methods for Generating and Evaluating Synthetic Longitudinal Patient Data: A Systematic ReviewJournal of Healthcare Informatics Research, 2025
- Differential Privacy2025
- Synthetic Data in Healthcare and Drug Development: Definitions, Regulatory Frameworks, IssuesCPT: Pharmacometrics & Systems Pharmacology, 2025
- Generative AI for synthetic data across multiple medical modalities: A systematic review of recent developments and challengesComputers in Biology and Medicine, 2025
- Tempered enthusiasm by interviewed experts for synthetic data and ELSI checklists for AI in medicineAI and Ethics, 2025
- Miscoding in the Nationwide Inpatient Sample Database Raises Questions About Validity for Arthroplasty ResearchThe Journal of Arthroplasty, 2024
- Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision MedicineClinical Pharmacology & Therapeutics, 2024
- Evaluation of Group Fairness Measures in Student Performance Prediction Problems2023
- Disclosure control using partially synthetic data for large‐scale health surveys, with applications to CanCORSStatistics in Medicine, 2013